Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Submitted by amarin on Wed, 03/01/2023 - 12:01
Home
News
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides…
-- Company Delivers Positive Free Cash Flow in Fourth Quarter 2022 Following U.S. Revenue Stabilization -- -- Previously Announced Cost Savings Program On-Track to Exceed $100 Million Target -- -- European, International Strategies Advancing At-Pace with Significant Progress Throughout 2022, and

Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Submitted by amarin on Wed, 03/01/2023 - 12:01
Home
News
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides…
-- Company Delivers Positive Free Cash Flow in Fourth Quarter 2022 Following U.S. Revenue Stabilization -- -- Previously Announced Cost Savings Program On-Track to Exceed $100 Million Target -- -- European, International Strategies Advancing At-Pace with Significant Progress Throughout 2022, and

Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders

Submitted by amarin on Tue, 02/28/2023 - 15:39
Home
News
Amarin Announces Preliminary Voting Results Following 2023 General Meeting of S…
DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that, based on the preliminary voting results provided by its proxy solicitors following the Company’s 2023 General Meeting of Shareholders (the

Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders

Submitted by amarin on Tue, 02/28/2023 - 15:38
Home
News
Amarin Announces Preliminary Voting Results Following 2023 General Meeting of S…
DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that, based on the preliminary voting results provided by its proxy solicitors following the Company’s 2023 General Meeting of Shareholders (the

Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand

Submitted by amarin on Tue, 02/28/2023 - 13:05
Home
News
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to…
DUBLIN, Ireland and BRIDGEWATER, N.J. and MELBOURNE, Australia, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) and CSL Seqirus today announced that the two companies have entered into an exclusive license and distribution agreement under which Amarin will license exclusive

Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand

Submitted by amarin on Tue, 02/28/2023 - 13:05
Home
News
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to…
DUBLIN, Ireland and BRIDGEWATER, N.J. and MELBOURNE, Australia, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) and CSL Seqirus today announced that the two companies have entered into an exclusive license and distribution agreement under which Amarin will license exclusive

Amarin Sets the Record Straight on Sarissa’s Latest Misstatements

Submitted by amarin on Mon, 02/27/2023 - 21:30
Home
News
Amarin Sets the Record Straight on Sarissa’s Latest Misstatements
DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today issued the following statement in response to Sarissa’s latest misstatements regarding the Company’s management compensation: The Amarin Board of
Subscribe to